---
schema_version: "secwatch.filing_event.v1"
accession: "0001214659-24-000421"
form_type: "8-K"
ticker: null
cik: "0001293310"
company_name: "HUMANIGEN, INC"
filed_at: "2024-01-08T23:59:59+00:00"
generated_at: "2026-06-07T02:03:13.996302+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Humanigen files Chapter 11, agrees to sell assets to CEO-controlled Taran for up to $20M

## Summary
- Chapter 11 filed Jan 3 in Delaware; company will operate as debtor-in-possession, pursue court-supervised sale.
- Enters asset purchase agreement with Taran Therapeutics (controlled by CEO Dr. Cameron Durrant) as stalking horse bidder for up to $20M ($2M cash + $18M milestones).
- DIP loan of up to $2M from Taran to fund operations; cash at closing offset by DIP loan balance.
- Common stock holders expected to experience complete or significant loss; trading is highly speculative.
- Sale subject to Bankruptcy Court approval, competing bids, and other conditions; closing expected within ~70 days of petition.

## SEC filing metadata
- accession: 0001214659-24-000421
- form_type: 8-K
- cik: 0001293310
- company_name: HUMANIGEN, INC
- filed_at: 2024-01-08T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 1.03, 2.03, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1293310/000121465924000421/0001214659-24-000421-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1293310/000121465924000421/o152468k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001214659-24-000421
- JSON: https://secwatch.observer/filing/0001214659-24-000421.json
- Plain text: https://secwatch.observer/filing/0001214659-24-000421.txt

## Key facts
- Debt Financings
  HUMANIGEN, INC incurred credit facility of up to $2 million with Taran maturing five (5) months after the Petition Date.
  - Instrument: credit facility
  - Principal: up to $2 million
  - Counterparty: Taran
  - Maturity: five (5) months after the Petition Date
  - Event: incurrence
  source text: Taran agreed to provide debtor in possession financing to the Company (the "DIP Loan"), pursuant to which, and subject to the satisfaction of the applicable conditions precedent contained therein, including the entry by the Bankruptcy Court of an appropriate order relating to the same (the "Interim DIP Order"), Taran would provide the Company with a DIP Loan in an aggregate principal amount of up to $2 million.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1293310/000121465924000421/0001214659-24-000421-index.htm
- Distress & Bankruptcy
  HUMANIGEN, INC entered chapter 11 in United States Bankruptcy Court for the District of Delaware (petition 2024-01-03).
  - Proceeding: chapter 11
  - Court: United States Bankruptcy Court for the District of Delaware
  - Petition: 2024-01-03
  source text: On January 3, 2024 (the “Petition Date”), Humanigen, Inc. (the “Company”) filed a voluntary petition under chapter 11 of Title 11 of the United States Code (the “Bankruptcy Code”) in the United States Bankruptcy Court for the District of Delaware (the “Bankruptcy Court”). The Company’s chapter 11 case (the “Chapter 11 Case”) is being administered under the caption, In re Humanigen, Inc. , Case No. 24-10003 (BLS).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1293310/000121465924000421/0001214659-24-000421-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.